Get 10 Free Leads on us
Use our Chrome Extension & instantly connect with prospects
Incyte
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of various therapeutics in the United States. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera cancers; and Iclusig, a kinase inhibitor to treat chronic myeloid leukemia and philadelphia-chromosome positive acute lymphoblastic leukemia.
incyte Corp
Incyte
INCYTE Inc
Incyte Ltd
Encyte
$3.8 B
2,524
2002
NASDAQ: INCY
Here's a list of some of the top trending technologies and APIs used by Incyte.
(16 Technologies)
(15 Technologies)
(10 Technologies)
(8 Technologies)
(8 Technologies)
Company | Employees | Revenue | Top technologies |
---|---|---|---|
Exelixis | 1,310 | $1.8 B | |
Vertex Pharmaceuticals | 5,400 | $10.2 B | |
Takeda Oncology | 2,315 | $781.5 M | |
Ionis Pharmaceuticals | 927 | $776.6 M | |
PTC Therapeutics | 1,402 | $938 M |